News and Events

CrossLife Tech’s IsoTARA COVID-19 Colorimetric Assay  has been developed and submitted for EUA approval

CrossLife Tech’s IsoTARA COVID-19 Colorimetric Assay has been developed and submitted for EUA approval

June 2020 | In response to the global outbreak of COVID-19, CrossLife Technologies has developed the IsoTARATM COVID-19 Colorimetric Assay to perform near...

Read more
CrossLife Tech’s Molecular Test  for the Novel Coronavirus,  CLT™ SARS-CoV-2 qRT-PCR, Has Developed.

CrossLife Tech’s Molecular Test for the Novel Coronavirus, CLT™ SARS-CoV-2 qRT-PCR, Has Developed.

June 2020 | In response to the global outbreak of the novel coronavirus disease (COVID-19), CrossLife Technologies has developed a real-time RT-PCR test, CLT™...

Read more
CrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic

CrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic

August 2018 | CrossLife has recently been awarded a Phase II Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test...

Read more

Where We Excel

RNA/DNA Molecular Diagnostics

RNA/DNA Molecular Diagnostics

Point-of-Care Diagnostics

Point-of-Care Diagnostics

Infectious Disease Detection

Infectious Disease Detection

Key Differentiators

Minimal Sample Preparation

Amplification without PCR

Low cost

Point-of-Care

Collaborators